20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Anteris Technologies Global Corp. Common Stock (AVR) operates in the MEDICAL DEVICES industry and is headquartered in Toowong, Australia with about 174 employees. Its market capitalization is roughly $809 million. In the fiscal year ended 2025-12-31, AVR reported $2M in revenue and ($94M) in net income.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.
Interactive charts & full statements → Open the AVR valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | $1M | $2M | $3M | $3M | $3M | $6M | $5M |
| Gross Profit | $1M | $0M | $1M | $1M | $0M | $2M | $3M |
| Gross Margin % | 100.0% | -16.6% | 46.8% | 32.1% | 9.3% | 32.7% | 61.5% |
| Operating Income (EBIT) | ($106M) | ($94M) | ($78M) | ($48M) | ($31M) | ($17M) | ($13M) |
| Operating Margin % | -10600.0% | -4908.2% | -2899.4% | -1760.3% | -972.1% | -289.2% | -243.0% |
| Net Income | ($103M) | ($94M) | ($76M) | ($46M) | ($31M) | ($17M) | ($12M) |
| Net Margin % | -10300.0% | -4921.3% | -2822.5% | -1682.8% | -954.9% | -294.5% | -215.8% |
| EBITDA | ($101M) | ($92M) | ($74M) | ($46M) | ($29M) | ($15M) | ($14M) |
| Earnings Per Share (EPS) | $-2.76 | $-2.55 | $-3.77 | $-1.28 | $-0.85 | $-0.48 | $-0.33 |
| Shares Outstanding (M) | 97M | 37M | 20M | 36M | 36M | 36M | 36M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1M | $0M | $0M | $0M | $1M | $1M | $1M | $1M |
| Gross Profit | $1M | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Gross Margin % | 76.9% | -9.9% | -65.8% | 71.3% | 76.0% | 62.8% | 61.3% | 42.3% |
| Operating Income (EBIT) | ($31M) | ($24M) | ($29M) | ($22M) | ($21M) | ($22M) | ($21M) | ($22M) |
| Operating Margin % | -3072.1% | -4859.7% | -9343.6% | -5190.0% | -3379.3% | -3917.3% | -3928.7% | -2846.2% |
| Net Income | ($29M) | ($23M) | ($29M) | ($22M) | ($21M) | ($22M) | ($19M) | ($22M) |
| Net Margin % | -2884.3% | -4660.7% | -9420.0% | -5185.1% | -3371.2% | -3932.4% | -3614.0% | -2842.6% |
| EBITDA | ($28M) | ($22M) | ($29M) | ($22M) | ($21M) | ($22M) | ($21M) | ($20M) |
| Earnings Per Share (EPS) | $-0.30 | $-0.28 | $-1.24 | $-0.94 | $-0.88 | $-0.93 | $-0.82 | $-0.61 |
| Shares Outstanding (M) | 97M | 83M | 24M | 24M | 24M | 24M | 24M | 36M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($87M) | ($78M) | ($61M) | ($35M) | ($29M) | ($14M) | ($11M) |
| Capital Expenditures (CapEx) | $2M | $2M | $2M | $2M | $2M | $1M | $0M |
| Free Cash Flow (FCF) | ($88M) | ($80M) | ($64M) | ($37M) | ($31M) | ($15M) | ($11M) |
| FCF Margin % | -8800.0% | -4169.2% | -2349.5% | -1353.9% | -971.1% | -257.6% | -207.1% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($21M) | ($29M) | ($19M) | ($18M) | ($20M) | ($21M) | ($18M) | ($14M) |
| Capital Expenditures (CapEx) | $1M | $0M | $0M | $1M | $1M | $0M | $0M | $1M |
| Free Cash Flow (FCF) | ($21M) | ($29M) | ($19M) | ($19M) | ($20M) | ($22M) | ($19M) | ($15M) |
| FCF Margin % | -2125.4% | -5833.4% | -6056.4% | -4434.5% | -3247.9% | -3909.5% | -3469.5% | -1905.6% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Total Assets | $273M | $23M | $81M | $31M | $16M | $21M | $10M |
| Cash & Cash Equivalents | $257M | $13M | $70M | $21M | $9M | $15M | $3M |
| Total Liabilities | $21M | $23M | $18M | $12M | $7M | $11M | $8M |
| Total Debt (Short + Long-Term) | $1M | $1M | $1M | $1M | $1M | $4M | $2M |
| Total Shareholders' Equity | $251M | $0M | $63M | $19M | $9M | $11M | $2M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AVR viewer.
About TickerBase · Data methodology & sources · Privacy · Terms